Total Slides: 32
Should all immunocompromised patients receive prophylaxis and/or empiric antifungal therapy or is it possible to limit it to particular patients at high risk on the basis of diagnostic procedures and risk assessment.
DOWNLOAD HERE
Should all immunocompromised patients receive prophylaxis and/or empiric antifungal therapy or is it possible to limit it to particular patients at high risk on the basis of diagnostic procedures and risk assessment.
DOWNLOAD HERE
0 comments:
Post a Comment